These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 11070113)
1. Steatosis in donor and transplant liver biopsies. Crowley H; Lewis WD; Gordon F; Jenkins R; Khettry U Hum Pathol; 2000 Oct; 31(10):1209-13. PubMed ID: 11070113 [TBL] [Abstract][Full Text] [Related]
2. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846 [TBL] [Abstract][Full Text] [Related]
3. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805 [TBL] [Abstract][Full Text] [Related]
4. Expanding postmortem donor pool using steatotic liver grafts: a new look. Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197 [TBL] [Abstract][Full Text] [Related]
5. Use of severely steatotic grafts in liver transplantation: a matched case-control study. McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095 [TBL] [Abstract][Full Text] [Related]
6. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Ryan CK; Johnson LA; Germin BI; Marcos A Liver Transpl; 2002 Dec; 8(12):1114-22. PubMed ID: 12474149 [TBL] [Abstract][Full Text] [Related]
7. Donor liver steatosis and graft selection for liver transplantation: a short review. Angelico M Eur Rev Med Pharmacol Sci; 2005; 9(5):295-7. PubMed ID: 16231593 [TBL] [Abstract][Full Text] [Related]
8. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern? Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875 [TBL] [Abstract][Full Text] [Related]
9. Does donor's fatty liver change impact on early mortality and outcome of liver transplantation. Nikeghbalian S; Nejatollahi SM; Salahi H; Bahador A; Sabet B; Jalaeian H; Geramizadeh B; Dehghani SM; Malek-Hosseini SA Transplant Proc; 2007 May; 39(4):1181-3. PubMed ID: 17524926 [TBL] [Abstract][Full Text] [Related]
10. An approach to the rational use of steatotic donor livers in liver transplantation. Urena MA; Moreno Gonzalez E; Romero CJ; Ruiz-Delgado FC; Moreno Sanz C Hepatogastroenterology; 1999; 46(26):1164-73. PubMed ID: 10370686 [TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil". Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915 [TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic steatohepatitis in children. Nanda K Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336 [TBL] [Abstract][Full Text] [Related]
13. The clinical associations with hepatic steatosis: a retrospective study. Samarasinghe D; Tasman-Jones C N Z Med J; 1992 Feb; 105(928):57-8. PubMed ID: 1542474 [TBL] [Abstract][Full Text] [Related]
14. Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters. Cieślak B; Lewandowski Z; Urban M; Ziarkiewicz-Wróblewska B; Krawczyk M Transplant Proc; 2009 Oct; 41(8):2985-8. PubMed ID: 19857657 [TBL] [Abstract][Full Text] [Related]
15. Donor liver dysfunction: application of a new scoring system to identify the marginal donor. Ferraz-Neto BH; Zurstrassen MP; Hidalgo R; Fonseca LE; Motta TD; Pandullo FL; Rezende MB; Meira-Filho SP; Sá JR; Afonso RC Transplant Proc; 2007 Oct; 39(8):2516-8. PubMed ID: 17954162 [TBL] [Abstract][Full Text] [Related]
16. High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation. Sharkey FE; Lytvak I; Prihoda TJ; Speeg KV; Washburn WK; Halff GA Hum Pathol; 2011 Sep; 42(9):1337-42. PubMed ID: 21420717 [TBL] [Abstract][Full Text] [Related]
17. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794 [TBL] [Abstract][Full Text] [Related]
18. Use of steatotic graft in living-donor liver transplantation. Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190 [TBL] [Abstract][Full Text] [Related]
19. [Steatosis and nonalcoholic steatohepatitis. A comparative analysis]. Piñol V; Bessa X; Bruguera M; Rodés J Gastroenterol Hepatol; 2000 Feb; 23(2):57-61. PubMed ID: 10726383 [TBL] [Abstract][Full Text] [Related]
20. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]